USDA estimates 2025 chicken meat production, first Bird Flu death in the U.S. and U.S. allocates $306 million to combat Avian Influenza: AviNews International Weekly News
aviNews InternationalSobre este episodio
30 January 2025
0
From AviNews International we are bringing you the latest news from the poultry sector with our colleague Edu Buil, so you do not miss any news!
🔗 In the following links you can find the complete news information:
USDA estimates 2025 chicken meat production: https://avinews.com/en/usda-estimates-2025-chicken-meat-production/
Louisiana reports first Bird Flu death in the U.S.: https://avinews.com/en/louisiana-reports-first-bird-flu-death-in-the-u-s/?swcfpc=1
U.S. allocates $306 million to combat Avian Influenza: https://avinews.com/en/u-s-allocates-306-million-to-combat-avian-influenza/?swcfpc=1
AviNews International, your partner in poultry farming
🔗 In the following links you can find the complete news information:
USDA estimates 2025 chicken meat production: https://avinews.com/en/usda-estimates-2025-chicken-meat-production/
Louisiana reports first Bird Flu death in the U.S.: https://avinews.com/en/louisiana-reports-first-bird-flu-death-in-the-u-s/?swcfpc=1
U.S. allocates $306 million to combat Avian Influenza: https://avinews.com/en/u-s-allocates-306-million-to-combat-avian-influenza/?swcfpc=1
AviNews International, your partner in poultry farming
Podcasts recomendados
Avinews International interviewed Martin Zuidhof at 2025 PSA Annual Meeting in Raleigh, NC
Avinews International interviewed Fernanda Castro at 2025 PSA Annual Meeting in Raleigh, NC
Avinews International interviewed Taiwo Alabi at 2025 PSA Annual Meeting in Raleigh, NC
Avinews International interviewed Meghan Davis at 2025 PSA Annual Meeting in Raleigh, NC
Avinews International interviewed Scott Kenney at 2025 PSA Annual Meeting in Raleigh, NC
Avinews International interviewed Andy Vance at 2025 PSA Annual Meeting in Raleigh, NC
Interview with Dr. Santiago Uribe-Diaz: “Advancements in Poultry Salmonella Vaccine Strategies: Balancing Safety and Immunogenicity”
